Finance

Beta
Lists
300485:SHE
Beijing Science Sun Pharmaceutical CoLtd
CN¥8.49
+1.31%
(+0.11) 1D
Jun 12, 12:54:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300485...
Open
CN¥8.38
High
CN¥8.51
Low
CN¥8.23
Mkt. cap
4.10B
Avg. vol.
6.32M
Volume
2.28M
Dividend
0.35%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
52-wk high
CN¥17.49
52-wk low
CN¥8.23
EPS
-CN¥0.04
Shares outstanding
481.67M
No. of employees
489
Open
CN¥8.38
High
CN¥8.51
Low
CN¥8.23
Mkt. cap
4.10B
Avg. vol.
6.32M
Volume
2.28M
Dividend
0.35%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
52-wk high
CN¥17.49
52-wk low
CN¥8.23
EPS
-CN¥0.04
Shares outstanding
481.67M
No. of employees
489
News stories
From sources across the web
About Beijing Science Sun Pharmaceutical CoLtd
CEO-
Employees489
FoundedMay 20, 1999
Headquarters-
SectorBiotechnology
Websitessyy.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
104.26M
111.83M
96.09M
90.44M
Cost of goods sold
34.35M
36.99M
41.28M
28.84M
Cost of revenue
34.35M
36.99M
41.28M
28.84M
Research and development expenses
15.44M
21.07M
21.11M
8.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.26M
53.16M
54.89M
43.44M
Operating expense
65.29M
74.27M
77.76M
52.07M
Total operating expenses
99.64M
111.26M
119.05M
80.91M
Operating income
4.62M
562.26K
-22.96M
9.53M
Other non operating income
28.20K
-72.37K
30.17K
-9.21K
EBT including unusual items
4.15M
7.54M
-46.89M
4.44M
EBT excluding unusual items
-4.04M
13.15M
-13.68M
11.47M
Income tax expense
-2.66M
4.74M
-6.13M
627.08K
Effective tax rate
-63.97%
62.91%
13.07%
14.12%
Other operating expenses
3.17M
554.25K
3.32M
1.05M
Net income
7.82M
4.07M
-37.29M
4.66M
Net profit margin
7.50%
3.64%
-38.81%
5.16%
Earnings per share
-
-
-
-
Interest and investment income
-
12.66M
9.34M
2.02M
Interest expense
-8.69M
-
-454.54K
-67.50K
Net interest expenses
-8.69M
12.66M
8.89M
1.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
16.96M
12.27M
-11.23M
21.25M
Gain or loss from assets sale
-111.88K
111.88K
-111.88K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer